Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Letter to the Editor

Response on Patient Adherence to Novel Oral Anticoagulants (NOACs) for the Treatment of Atrial Fibrillation and Occurrence of Associated Bleeding Events: A Systematic Review and Meta-analysis

Author(s): Abdulla Shehab*, Akshaya S. Bhagavathula, Tamrat B. Abebe, Tadessa M. Abegaz, Asim A. Elnour, Hani M. Sabbour, Masood Uzzafer, Hersi Ahmad and Adel K. Hamad

Volume 17, Issue 4, 2019

Page: [352 - 353] Pages: 2

DOI: 10.2174/1570161117999190429124137

[1]
Albert V, Arnet I, Gudka S. Comment on patient adherence to novel oral anticoagulants (NOACs) for the treatment of atrial fibrillation and occurrence of associated bleeding events: A systematic review and meta-analysis. Curr Vasc Pharmacol 2019; 17: 350-1.
[2]
Shehab A, Bhagavathula AS, Abebe TB, et al. Patient adherence to novel oral anticoagulants (NOACs) for the treatment of atrial fibrillation and occurrence of associated bleeding events: A systematic review and meta-analysis. Curr Vasc Pharmacol 2019; 17: 341-9.
[3]
Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: Terminology and definitions. Value Health 2008; 11: 44-7.
[4]
Karve S, Cleves MA, Helm M, et al. Good and poor adherence: Optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 2009; 25: 2303-10.
[5]
Woltmann EM, Valenstein M, Welsh DE, et al. Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness. Psychol Serv 2007; 58: 864-7.
[6]
Lehmann A, Aslani P, Ahmed R, et al. Assessing medication adherence: Options to consider. Int J Clin Pharm 2014; 36: 55-69.
[7]
Raebel MA, Schmittdiel J, Karter AJ, et al. Standardizing terminology and definition of medication adherence and persistence in research employing electronic databases. Med Care 2013; 51: 11-21.
[8]
Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012; 73: 691-705.
[9]
Gorst‐Rasmussen A, Skjøth F, Larsen TB, et al. Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: A nationwide cohort study. J Thromb Haemost 2015; 13: 495-504.
[10]
Hanemaaijer S, Sodihardjo F, Horikx A, et al. Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands. Int J Clin Pharm 2015; 37: 1128-35.

© 2024 Bentham Science Publishers | Privacy Policy